About the Company
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
32403
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BAX News
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers ...
Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Baxter International, Inc. BAX recently announced the expansion of its Pharmaceutical portfolio with the launch of five ...
Baxter Is Deeply Undervalued
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.
Baxter International Inc BAX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Baxter expands pharma portfolio with launching five injectable products in US
Baxter expands pharma portfolio with launching five injectable products in US: Deerfield, Illinois Saturday, April 13, 2024, 11:00 Hrs [IST] Baxter International Inc., a global le ...
Baxter International Breaks Below 200-Day Moving Average - Notable for BAX
In trading on Tuesday, shares of Baxter International Inc (Symbol: BAX) crossed below their 200 day moving average of $39.74, changing hands as low as $39.51 per share. Baxter International Inc ...
Baxter International Inc BAX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
baxter international inc.
Baxter International Inc. BAX 0.27% is in advanced talks to buy medical-equipment maker Hill-Rom Holdings Inc. HRC 0.96% for around $10 billion, according to people familiar with the matter.
Loading the latest forecasts...